Celltrion
068270.KS
$180.32
Share price
-1.89%
Change (1 day)
-10.39%
Change (1 year)
Categories
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.
EPS for Celltrion (068270.KS)
EPS in 2023 (TTM): $4.50
According to Celltrion 's latest financial reports the company's current EPS (TTM) is $4.75. In 2022 the company made an earnings per share (EPS) of $4.63 a decrease over its 2021 EPS that were of $5.50.
EPS history for Celltrion from 2007 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $4.50 | -2.81% |
| 2022 | $4.63 | -15.84% |
| 2021 | $5.50 | 12.77% |
| 2020 | $4.87 | 70.79% |
| 2019 | $2.85 | 15.63% |
| 2018 | $2.47 | -33.13% |
| 2017 | $3.69 | 141.17% |
| 2016 | $1.53 | 8.28% |
| 2015 | $1.41 | 11.28% |
| 2014 | $1.27 | 16.37% |
| 2013 | $1.09 | -67.42% |
| 2012 | $3.35 | 84.22% |
| 2011 | $1.82 | 62.13% |
| 2010 | $1.12 | 80.61% |
| 2009 | $0.62 | -559.63% |
| 2008 | -$0.14 | -123.16% |
| 2007 | $0.58 |